Systematic Literature Review of Real-World Effectiveness Results Data for First-Line Ibrutinib in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

• Main Authors: Philip Lee (Author), Kristin D. Kistler (Author), Luc Douyon (Author), Raisa Volodarsky (Author), Alex Young (Author), Sudeep Karve (Author), Swetha Challagulla (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2022-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background and Objective Ibrutinib, an oral Bruton's tyrosine kinase inhibitor, has demonstrated efficacy as a first-line treatment for chronic lymphocytic leukemia in multiple, phase III, randomized clinical trials. This systematic literature review assessed the clinical effectiveness...